Results 51 to 60 of about 33,888 (298)

Introducing the "ChOLE" Classification and Its Comparison to the EAONO/JOS Consensus Classification for Cholesteatoma Staging.

open access: yesOtology and Neurotology, 2019
: Many previous attempts have been made to classify or categorize cholesteatomas. Recently, the European Academy of Otology and Neurotology and the Japanese Otological Society proposed a classification system based primarily on extension and ...
T. Linder   +4 more
semanticscholar   +1 more source

Relationship between clinicopathological characteristics and CYLD expression in patients with cholesteatoma.

open access: yesPLoS ONE, 2020
Middle ear cholesteatoma is a destructive disease in which inflammation plays an important role in development and progression, and there are currently no biomarkers predicting prognosis or recurrence.
Shunsuke Miyake   +8 more
doaj   +1 more source

Congenital cholesteatoma of the middle ear - uncommon clinical presentation [PDF]

open access: yes, 2014
Introduction. Congenital cholesteatoma of the middle ear is un uncommon and yet not well-defined disease. Only few cases of cholesteatoma in the fossa ovalis with unusual clinical presentation have been reported in medical literature.
Arsović Nenad   +4 more
core   +1 more source

Cholesteatoma Severity Determines the Risk of Recurrent Paediatric Cholesteatoma More Than the Surgical Approach

open access: yesJournal of Clinical Medicine
Objective: To evaluate factors that influence the rate of cholesteatoma recurrence (growth of new retraction cholesteatoma) in children. Methods: Review of children with primary acquired or congenital cholesteatoma.
Adrian L James
semanticscholar   +1 more source

Efficacy of Otoendoscopy for Residual Cholesteatoma Detection During Microscopic Chronic Ear Surgery

open access: yesJournal of International Advanced Otology
BACKGROUND: The aim of this article is to determine the efficacy of otoendoscopy during microscopic cholesteatoma surgery on residual cholesteatoma rates postoperatively.
Floor Couvreur   +3 more
doaj   +1 more source

Expression of CYLD and NF-κB in Human Cholesteatoma Epithelium

open access: yesMediators of Inflammation, 2010
The tumor suppressor CYLD is a deubiquitinating enzyme that inhibits activation of the NF-κB, which has key roles in inflammation and apoptosis. We hypothesized that CYLD may regulate the NF-κB signaling pathway in cholesteatoma.
Jae Yong Byun   +4 more
doaj   +1 more source

Do MPV and NLR Values Differentiate Cholesteatoma from Chronic Otitis Media?

open access: yesVan Tıp Dergisi, 2021
INTRODUCTION: Chronic active otitis media(without cholesteatoma)and cholesteatoma are common ear pathologies that progress with a chronic inflammatory process, often causing damage, functional and anatomical loss.
Mehmet Aslan, Mehmet Turan Çiçek
doaj   +1 more source

Optical Imaging With a High-Resolution Microendoscope to Identify Cholesteatoma of the Middle Ear [PDF]

open access: yes, 2013
Objectives/Hypothesis: High-resolution optical imaging is an imaging modality that allows visualization of structural changes in epithelial tissue in real time.
Ahn   +25 more
core   +1 more source

A Role for Mast Cell-Mediated Antibodies in the Formation of Cholesteatoma and Cholesteatoma-Induced Bone Erosion

open access: yesDiagnostics, 2023
The study aimed to evaluate the effects and relationships between mast cells in the matrix, mast cell enzymes tryptase and chymase, epithelial proliferation, microvascular density, and bone destruction in cholesteatoma.
Çiğdem Özdemir   +7 more
doaj   +1 more source

Non-cholesteatomatous suppurative otitis media: facial nerve palsy in an immunocompromised patient [PDF]

open access: yes, 1995
A 47-year-old man developed a complete facial nerve palsy secondary to non-cholesteatomatous suppurative otitis media. At operation, this was seen to be due to destruction of the nerve from halfway along the horizontal segment to a point just distal to ...
Hartley, C   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy